ISHLT2025: ECP Immunomodulation in Thoracic Transplantation Challenge Grant Selection Session (Non-CME)
29 April, 2025 11:45 a.m. to 12:45 p.m. CEST
Supported by THERAKOS HEALTHCARE LIMITED
This session will showcase presentations from the five finalists for the ISHLT Extracorporeal Photopheresis Immunomodulation in Thoracic Transplantation Challenge Grant, which will be scored by on site judges. This research grant is aimed at advancing the use of Extracorporeal photopheresis (ECP) immunomodulation to improve patient survival and health-related quality of life (HRQoL) and improve or stabilize organ function in thoracic transplant patients.
The winner will be announced during General Session III on Wednesday, 30 April.
Grant Finalists
Andrea Fernandez Valledor, MD
New York Presbyterian / Weill Cornell Medical Center
New York, NY USA
Research Proposal Title: Utility of Extracorporeal Photopheresis in Chronic Antibody-Mediated Rejection
Jerome Le Pavec, MD, PhD
Hopital Marie Lannelongue
Le Plessis Robinson, France
Research Proposal Title: Biomarker Guided Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction: The BioCLAD-ECP Study
Naureen Narula, MD
University of Kentucky
Lexington, KY USA
Research Proposal Title: Development and Validation of a Predictive Biomarker Signature for Therapeutic Response to Extracorporeal Photopheresis in Lung Transplant Recipients at Risk for CLAD
Ilaria Righi, MD, PhD
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano
Milan, Italy
Research Proposal Title: Italian Collaborative Network for ECP Treatment of CLAD (PHOR-LUCY)
Alexander Wein, MD, PhD
Washington University School of Medicine
St. Louis, MO USA
Research Proposal Title: Multiomic Characterization of Obliterative Bronchiolitis Lesions in Extracorporeal Responders and Non-Responders